Confocal NL key facts
as of Oct 2026- Developer of plug-and-play confocal microscopes committed to improving the microscopy imaging experience of researchers around the world.
- Confocal NL is valued at approximately $12.9M as of Oct 2026 (last reported valuation).
- It has raised $8.5M; the latest was PE Growth/Expansion in Jul 2025.
- Notable investors include Innovatiefonds Noord-Holland, Rijksdienst voor Ondernemend Nederland, Attract EU, Coöperatieve Rabobank, ECFG — 9 tracked in total.
- Status: Privately Held (backing).
Confocal NL's last reported valuation, Jul 2022. Nothing priced has surfaced since.
- ·Watch Confocal NL: the Monday email on marks, rounds and moves
Confocal NL funding rounds
No funding rounds for Confocal NL are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Confocal NL valuation
Confocal NL's last reported valuation was $12.9 million in Jul 2022. No priced round, secondary trade or fund mark has surfaced since.
Confocal NL investors
9 investors are on record for Confocal NL, including Innovatiefonds Noord-Holland, Rijksdienst voor Ondernemend Nederland, Attract EU and Coöperatieve Rabobank.
About Confocal NL
Developer of plug-and-play confocal microscopes committed to improving the microscopy imaging experience of researchers around the world. The company's laser scanning confocal system with the re-scanning confocal microscopy (RCM) technology allows enhanced resolution in combination with low laser intensity, thereby helping its users by making confocal technology without extensive microscopy experience.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2013
- Employees
- 17
- Website
- confocalnl.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.